Panel Discussion on Equity, Diversity & Inclusion (ED&I): Expediting Liquid Biopsy Development & Validation for Early Screening to Advance Equity in Personalized Treatment

Time: 9:30 am
day: Day One


  • What strategies can be implemented to address disparities in early cancer screening using liquid biopsies?
  • What steps are being taken to validate liquid biopsy assays across diverse patient populations, considering variations in genetic and molecular profiles, to tailor inclusive personalized treatment strategies?
  • How to promote diversity and inclusion in research related to liquid biopsy development and validation?
  • What are the benefits of capturing a diverse and inclusive genetic and molecular characteristics for advancing equity in early screening?